Women's Satisfaction and Adherence to Vulvovaginal Atrophy Treatments

Satisfaction and Treatment Adherence in Women With Vulvovaginal Atrophy: A Cross-sectional Study (CRETA Study)

The primary objective of this study is to describe and assess participants' satisfaction with current vulvovaginal atrophy (VVA) treatment.

This study is designed as a multicenter, cross-sectional, descriptive, observational study.

Inclusion Criteria:

• Women with natural menopause established for at least one year.
• Absence of menstruation for at least one year.
• Mild, moderate or severe VVA diagnosis.
• Currently under treatment with either Ospemifene, Local Oestrogen Therapy or moisturizers for at least 3 months in accordance with the approved SmPC and/or Patient Leaflet
• Patients providing writing informed consent for participating in the study.

Exclusion Criteria:

• Women who have never been previously treated for VVA
• Women who have discontinued their VVA treatment due to a contraindication in the study group drug.
• Patients using more than one VVA treatment at a time (except for lubricants).
• Breastfeeding, pregnancy or under any kind of systemic hormonal treatment that causes amenorrhea.
• Local phytotherapy for VVA.